Biomarin Pharmaceutical Inc (BMRN)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	167,645	141,561	-64,080	854,029	-23,848
Total assets	US$ in thousands	6,841,600	6,375,070	6,004,770	5,848,020	4,690,040
ROA		2.45%	2.22%	-1.07%	14.60%	-0.51%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $167,645K ÷ $6,841,600K
= 2.45%

Biomarin Pharmaceutical Inc's return on assets (ROA) has fluctuated over the past five years. In 2023, the ROA was 2.45%, showing a slight improvement from the previous year's 2.22%.

However, in 2021, the company experienced a negative ROA of -1.07%, indicating that the company's assets generated a net loss during that period. On the other hand, in 2020, the ROA was notably high at 14.60%, suggesting that the company effectively utilized its assets to generate profits.

In 2019, Biomarin Pharmaceutical Inc recorded a negative ROA of -0.51%, indicating a period of asset underutilization or inefficiency. Overall, the company's ROA performance has been mixed over the past five years, with fluctuations reflecting changes in the company's asset management and profitability. It is essential for Biomarin to closely monitor and improve its ROA to ensure efficient utilization of its assets and maximize shareholder value.